null
SMILES C[C@H](N1CC[C@@](CCCO)(OC1=O)c1ccccc1)c1ccc(cc1)-c1ccc(=O)n(C)c1
InChI Key InChIKey=BUIPWQYAVGFZFQ-CCLHPLFOSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 6 hits for monomerid = 107656
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Affinity DataIC50: 1.44nMAssay Description:The inhibition of a microsomal preparation of 11β-HSD1 by compounds of the invention was measured essentially as previously described (K. Solly,...More data for this Ligand-Target Pair
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Affinity DataIC50: 3.42nMAssay Description:Inhibition assay using 11β-HSD1 in the presence of 50% human plasma. More data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Affinity DataIC50: 5.00E+4nMT: 2°CAssay Description:The assay was based on a method published by Moody et al. (Xenobiotica 1999). The inhibition of cytochrome P450 3A4-isoenzyme catalysed N-demethylati...More data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Affinity DataIC50: 5.00E+4nMT: 2°CAssay Description:Using a procedure similar to that described in Biological Test Example 6, the inhibition of cytochrome P450 2C9-isoenzyme catalysed O-demethylation o...More data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Affinity DataIC50: 1.43E+4nMAssay Description:The inhibition of recombinant CYP2C9 by compounds of the invention was measured using a commercial kit from Invitrogen (cat #2859).More data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH
US Patent
Affinity DataIC50: 2.70E+4nMT: 2°CAssay Description:Using a procedure similar to that described in Biological Test Example 6, the inhibition of cytochrome P450 2C19-isoenzyme catalysed N-demethylation ...More data for this Ligand-Target Pair